Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Acta Otorrinolaringol Esp (Engl Ed). 2022 Mar-Apr;73(2):82-88. doi: 10.1016/j.otoeng.2020.12.001.
Acta Otorrinolaringol Esp (Engl Ed). 2022.
PMID: 35397828
Clinical Trial.
Efficacy of cidofovir versus bevacizumab in recurrent respiratory papillomatosis: A randomized, double-blind, placebo-controlled pilot study.
Ablanedo-Terrazas Y, Estrada-Camacho O, Alvarado-de la Barrera C, Ramírez-García A, Tona-Acedo G, Bross-Soriano D, Schimelmitz-Idi J.
Ablanedo-Terrazas Y, et al. Among authors: estrada camacho o.
Acta Otorrinolaringol Esp (Engl Ed). 2021 Jun 18:S0001-6519(21)00030-3. doi: 10.1016/j.otorri.2020.12.001. Online ahead of print.
Acta Otorrinolaringol Esp (Engl Ed). 2021.
PMID: 34154795
English, Spanish.
Item in Clipboard
Cite
Cite